Life Sciences Information Management Platform Uses Aspera’s
Databiology’s Software as a Service (
The fast and reliable transfer of this research data is essential, particularly in clinical environments where a patient’s health is dependent on the results of the analysis. The challenge is that raw data sizes can reach several hundred gigabytes in size, especially for genomic sequencing sets. With Aspera, Databiology will benefit from the reliable, high-speed transfer of these data sets to and from the DBE platform, reducing its reliance on slow and costly physical shipments of hard drives.
Aspera consistently delivers predictable and reliable transfer times, avoiding unexpected delays and transfer failures associated with traditional network protocols. This enables researchers to enjoy more efficient workflows between both internal user groups and third-party research partners. The technology also features built-in security capabilities such as encryption in transit and at rest to protect valuable assets throughout the transfer process.
For joint clients and end users, Databiology’s open architecture enables interoperability with any scientific, commercial and clinical applications, while Aspera gives them the flexibility to use their existing infrastructure to achieve maximum transfer speeds.
“We’ve relied on Aspera in extremely poor quality transmission environments, for instance, sending large data sets from laptops over WiFi networks,” said
“The life sciences industry is constantly searching for new and innovative ways to improve data sharing and analysis in support of clinical research,” said
Aspera (Booth 356) and Databiology (Booth 454) will demonstrate their suite of products and services at Bio-IT World Expo from
Databiology is a privately held global life sciences software and services company based in Oxford and
Databiology for Enterprise is an Omics specific platform that enables interoperability and facilitates the sustainable use of best-in-class scientific, commercial and clinical applications and services across the entire omics life cycle. We focus on the provision of technology to manage the increasingly large and complex R&D data assets so that our clients can focus their capacity and efforts on making faster and more economically effective scientific breakthroughs.
This information was brought to you by Cision http://news.cision.com
Most Popular Stories
- National Retail Federation Reduces Sales Forecast
- Pandora Tumbles in Late Trading
- Sporty Ford Fiesta Fires on All 3 Cylinders
- Stop-Start Engines Save Gas, Reduce Emissions
- World Tensions Don't Curb Enthusiasm for Stocks
- Russia Fears Lasting Damage From Ukraine Crisis
- Visa, Amazon Results Drag Down the Street
- U.K. Economy Surpasses Pre-Crisis Peak
- Hispanic Leader Goes the Extra Mile
- Ohio State Band Chief Fired After Probe